DIRECT BIOLOGICS LLC

In News

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

Rapid Micro Biosystems Receives Multi-System Order from Samsung Biologics to Expand Growth Direct Platform for Microbial Quality Control Automation - Quiver Quantitative

Quiver Quantitative - Mar 12, 2026

Acute Respiratory Distress Syndrome Clinical Trial Pipeline - GlobeNewswire

GlobeNewswire - Apr 09, 2026

FibroBiologics (Nasdaq: FBLG) prices $1.7M direct sale and related $1.7M warrants - Stock Titan

Stock Titan - Dec 15, 2025

Direct Biologics - The Pharma Letter

The Pharma Letter - Jun 30, 2024

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - newswire.com

newswire.com - Jan 12, 2021

Bankruptcy Law And Charging Order Law Collide Again In Pettine - Forbes

Forbes - Nov 23, 2023

Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer - citybiz

citybiz - Feb 15, 2023

For Nascent Exosome Field, One Company’s Win Is Everyone’s Gain - Citeline News & Insights

Citeline News & Insights - Sep 30, 2024

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo™ - BioInformant

BioInformant - Aug 02, 2020

ADMA Biologics (ADMA) CEO exercises options and sells 21K shares - Stock Titan

Stock Titan - Mar 17, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment